Italy-USA Bilateral Trade Analysis 2023

Complete trade statistics: $95.80B total volume โ€ขItaly surplus: $42.84B

Italy โ†’ USA

$69.32B

Exports (2023)

USA โ†’ Italy

$26.48B

Imports (2023)

Trade Balance

$42.84B

Surplus for Italy

Total Trade

$95.80B

Combined Volume

Trade Flow Visualization

Direct trade relationship between Italy and USA. Green line shows exports from Italy, red line shows imports.

Detailed Product Trade Analysis

Comprehensive breakdown of trade flows by product category, revealing the specialized nature of the Italy-USA commercial relationship and competitive positioning in global markets.

Italy โ†’ USA Exports

$69.32B
2023 Total

Export Market Intelligence

Product Diversity:
Highly Diversified
Market Share:
4.5% top product
1Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$3.10B
4.5% of exports
2Petroleum oils and oils from bituminous minerals, not crude: preparations n.e.c. containing by weight 70% or more of petroleum oils or oils from bituminous minerals: these being the basic constituents of the preparations: waste oils
$2.44B
3.5% of exports
3Vehicles: with only spark-ignition internal combustion reciprocating piston engine, cylinder capacity over 3000cc
$2.16B
3.1% of exports
4Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale
$1.81B
2.6% of exports
5Vehicles: with only spark-ignition internal combustion reciprocating piston engine, cylinder capacity over 1500 but not over 3000cc
$1.57B
2.3% of exports
6Vaccines: for human medicine
$1.46B
2.1% of exports
7Wine: still, in containers holding 2 litres or less
$1.39B
2.0% of exports
8Jewellery: of precious metal (excluding silver) whether or not plated or clad with precious metal, and parts thereof
$1.37B
2.0% of exports
9Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale
$1.16B
1.7% of exports
10Sunglasses: corrective, protective or other
$1.11B
1.6% of exports

๐ŸŽฏ Strategic Export Focus

Italy's export portfolio to USA demonstrates strong diversification across multiple sectors, with medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale representing a key competitive advantage in this bilateral market.

USA โ†’ Italy Imports

$26.48B
2023 Total

Import Dependency Profile

Supply Diversity:
Well Diversified
Critical Imports:
17.9% concentration
1Oils: petroleum oils and oils obtained from bituminous minerals, crude
$4.73B
17.9% of imports
2Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts
$2.71B
10.2% of imports
3Petroleum gases and other gaseous hydrocarbons: liquefied, natural gas
$2.37B
9.0% of imports
4Waste and scrap of precious metals: waste and scrap of precious metals including metal clad with precious metals, other than that of gold and platinum and excluding ash which contains precious metal or precious metal compounds
$692.18M
2.6% of imports
5Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale
$483.98M
1.8% of imports
6Aircraft and spacecraft: parts of aeroplanes or helicopters n.e.c. in heading no. 8803
$413.66M
1.6% of imports
7Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$412.38M
1.6% of imports
8Coal: bituminous, whether or not pulverised, but not agglomerated
$400.92M
1.5% of imports
9Turbines: parts of gas turbines (excluding turbo-jets and turbo-propellers)
$389.74M
1.5% of imports
10Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material
$321.09M
1.2% of imports

๐Ÿ“ฆ Import Strategy Analysis

Italy's import pattern from USA reveals significant dependencyin oils: petroleum oils and oils obtained from bituminous minerals, crude, highlighting complementary economic structures and potential supply chain optimization opportunities.

Competitive Trade Position Analysis

๐Ÿ†

Market Leadership

Italy demonstrates competitive strength in exportingmedicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale to USA, leveraging comparative advantages.

Export Leader in 20+ Categories
๐Ÿ”„

Trade Complementarity

The bilateral relationship showsmoderatecomplementarity, with each country specializing in different sectors.

Specialized Exchange
๐Ÿ“ˆ

Growth Potential

The $95.80B trade volume indicates substantial economic integration with room for expansion in emerging sectors.

Major Partnership

Executive Summary: Italy-USA Trade Relationship

Key Trade Highlights 2023

  • Total Trade Volume: $95.80 billionrepresenting a significant bilateral economic relationship
  • Trade Balance: Italy maintains a surplus of $42.84 billion
  • Export Focus: Italy's primary exports include medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, petroleum oils and oils from bituminous minerals, not crude: preparations n.e.c. containing by weight 70% or more of petroleum oils or oils from bituminous minerals: these being the basic constituents of the preparations: waste oils, vehicles: with only spark-ignition internal combustion reciprocating piston engine, cylinder capacity over 3000cc
  • Import Dependencies: Key imports from USA include oils: petroleum oils and oils obtained from bituminous minerals, crude, polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts, petroleum gases and other gaseous hydrocarbons: liquefied, natural gas

Strategic Trade Indicators

Trade IntensityHigh
Export DiversificationDiversified
Trade Balance HealthImbalanced

๐Ÿ“ˆ Market Position: This bilateral trade relationship represents one of the world's largest trade partnerships, with complementary economic strengths driving sustained commercial exchange.

Historical Trade Analysis & Economic Context

Trade Evolution Timeline

2019-2023: Recent Trends

Current trade volume of $95.80B represents the culmination of evolving bilateral commercial relationships, influenced by global supply chain shifts and changing economic priorities.

2015-2019: Growth Period

Sustained expansion in bilateral trade driven by complementary economic structures, with Italy leveraging its comparative advantages in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale.

2010-2015: Foundation Building

Establishment of modern trade frameworks and reduction of barriers, facilitating increased commercial exchange and investment flows between the two economies.

Pre-2010: Early Development

Initial stages of bilateral trade relationship development, with focus on traditional export-import patterns and gradual market integration.

Key Economic Drivers

1

Comparative Advantage

Italy's specialization in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail salecomplements USA's demand patterns, creating natural trade synergies.

2

Supply Chain Integration

Deep integration in global value chains has strengthened bilateral linkages, particularly in oils: petroleum oils and oils obtained from bituminous minerals, crude.

3

Market Access & Trade Policy

Favorable trade agreements and market access conditions have facilitated the growth of this $95.80B bilateral relationship.

Trade Pattern Insights

Trade ComplementarityAsymmetric
Seasonal VariationsModerate
Product ConcentrationLow
Market DependencyHigh
๐Ÿ”ฎ

Trade Relationship Outlook

The $95.80B bilateral trade volume positions this relationship for continued growth, supported by technological advancement, evolving consumer preferences, and strengthening economic ties. Key opportunities lie in expanding cooperation in emerging sectors while managing potential supply chain vulnerabilities.

Economic Impact & Strategic Outlook

Economic Impact Assessment

๐Ÿ’ฐ

Trade Volume Impact

The $95.80 billion bilateral trade volume represents a major economic driverfor both economies.

Economic Significance: Very High
๐Ÿญ

Industrial Integration

Trade flows in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale and oils: petroleum oils and oils obtained from bituminous minerals, crude demonstrate deep industrial linkages and supply chain integration.

Supply Chain Integration: Diversified
โš–๏ธ

Trade Balance Effects

Italy's trade surplus of $42.84 billion strengthens its overall economic position in this bilateral relationship.

Balance Impact: Export Advantage

Strategic Future Outlook

๐Ÿš€Growth Opportunities

Emerging Sectors
Technology transfer and innovation cooperation in petroleum oils and oils from bituminous minerals, not crude: preparations n.e.c. containing by weight 70% or more of petroleum oils or oils from bituminous minerals: these being the basic constituents of the preparations: waste oils present expansion opportunities.
Market Diversification
Beyond current focus on oils: petroleum oils and oils obtained from bituminous minerals, crude, new product categories offer potential for trade expansion.

โš ๏ธRisk Factors

Supply Chain Vulnerabilities
High trade imbalance may create supply chain risks
Market Competition
Global competition in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale may affect future market positioning.

๐ŸŽฏStrategic Recommendations

  • Strengthen cooperation in high-value sectors beyond current trade patterns
  • Develop alternative supply chains to reduce dependency risks
  • Explore joint ventures in emerging technology sectors
  • Enhance trade facilitation and reduce transaction costs

Market Position & Competitive Summary

The bilateral trade relationship between Italy and USA represents a total trade volume of $95.80 billion in 2023. This partnership demonstrates a favorable trade balance for Italy, with exports exceeding importsby $42.84 billion.

Export Strengths

Italy's exports to USA total $69.32 billion, with competitive advantages in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, representing $3.10B or4.5% of bilateral exports.

Import Dependencies

Imports from USA amount to $26.48 billion, highlighting economic interdependence in oils: petroleum oils and oils obtained from bituminous minerals, crude, with Oils: petroleum oils and oils obtained from bituminous minerals, crude comprising17.9% of total imports.

The trade relationship reflects broader economic patterns and comparative advantages. The trade surplus indicates Italy's competitive position in this bilateral relationship. This partnership is characterized by complementary trade flows, with each country specializing in different product categories based on their respective economic strengths, industrial capabilities, and position in global value chains.

Download Bilateral Trade Data

Access detailed trade data between Italy and USA in multiple formats.

Data Source: CEPII BACI (Base pour l'Analyse du Commerce International) โ€ข Last Updated: January 2025 โ€ข Coverage: 1995-2023